Command Polymers Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 8, 2025, 6:57 pm

Quick Insight

Command Polymers Ltd, based in Mouza Malancha, West Bengal, is currently trading at a price of ₹32.7 with a market capitalization of ₹30.6 Cr. The company's financial metrics reveal a P/E ratio of 54.7, indicating a relatively high valuation, while ROE stands at 3.64% and ROCE at 4.74%, suggesting room for improvement in capital efficiency. With a healthy operating profit margin of 51.32% and a moderate P/BV ratio of 2.26x, Command Polymers seems to be managing costs effectively. However, the low net profit of ₹0.56 Cr and significant borrowing of ₹10.84 Cr raise concerns about profitability and leverage. Investors should monitor the company's performance closely to assess its ability to generate sustainable returns and manage debt effectively in the future.

Competitors of Command Polymers Ltd

All Competitor Stocks of Command Polymers Ltd

Quarterly Result

Last Updated: May 31, 2025, 6:27 am

Below is a detailed analysis of the quarterly data for Command Polymers Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 2.28 Cr.. The value appears to be declining and may need further review. It has decreased from 9.15 Cr. (Dec 2024) to 2.28 Cr., marking a decrease of 6.87 Cr..
• For Expenses, as of Mar 2025, the value is 1.11 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 8.40 Cr. (Dec 2024) to 1.11 Cr., marking a decrease of 7.29 Cr..
• For Operating Profit, as of Mar 2025, the value is 1.17 Cr.. The value appears strong and on an upward trend. It has increased from 0.75 Cr. (Dec 2024) to 1.17 Cr., marking an increase of 0.42 Cr..
• For OPM %, as of Mar 2025, the value is 51.32%. The value appears strong and on an upward trend. It has increased from 8.20% (Dec 2024) to 51.32%, marking an increase of 43.12%.
• For Other Income, as of Mar 2025, the value is 0.03 Cr.. The value appears strong and on an upward trend. It has increased from 0.02 Cr. (Dec 2024) to 0.03 Cr., marking an increase of 0.01 Cr..
• For Interest, as of Mar 2025, the value is 0.54 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.31 Cr. (Dec 2024) to 0.54 Cr., marking an increase of 0.23 Cr..
• For Depreciation, as of Mar 2025, the value is 0.35 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.39 Cr. (Dec 2024) to 0.35 Cr., marking a decrease of 0.04 Cr..
• For Profit before tax, as of Mar 2025, the value is 0.31 Cr.. The value appears strong and on an upward trend. It has increased from 0.07 Cr. (Dec 2024) to 0.31 Cr., marking an increase of 0.24 Cr..
• For Tax %, as of Mar 2025, the value is -29.03%. The value appears to be improving (decreasing) as expected. It has decreased from 114.29% (Dec 2024) to -29.03%, marking a decrease of 143.32%.
• For Net Profit, as of Mar 2025, the value is 0.41 Cr.. The value appears strong and on an upward trend. It has increased from -0.01 Cr. (Dec 2024) to 0.41 Cr., marking an increase of 0.42 Cr..
• For EPS in Rs, as of Mar 2025, the value is 0.44. The value appears strong and on an upward trend. It has increased from -0.01 (Dec 2024) to 0.44, marking an increase of 0.45.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 2:08 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:32 pm

Below is a detailed analysis of the balance sheet data for Command Polymers Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 9.38 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 9.38 Cr..
• For Reserves, as of Mar 2025, the value is 6.29 Cr.. The value appears strong and on an upward trend. It has increased from 5.73 Cr. (Mar 2024) to 6.29 Cr., marking an increase of 0.56 Cr..
• For Borrowings, as of Mar 2025, the value is 10.84 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 10.76 Cr. (Mar 2024) to 10.84 Cr., marking an increase of 0.08 Cr..
• For Other Liabilities, as of Mar 2025, the value is 0.59 Cr.. The value appears to be improving (decreasing). It has decreased from 1.39 Cr. (Mar 2024) to 0.59 Cr., marking a decrease of 0.80 Cr..
• For Total Liabilities, as of Mar 2025, the value is 27.10 Cr.. The value appears to be improving (decreasing). It has decreased from 27.26 Cr. (Mar 2024) to 27.10 Cr., marking a decrease of 0.16 Cr..
• For Fixed Assets, as of Mar 2025, the value is 12.11 Cr.. The value appears to be declining and may need further review. It has decreased from 12.33 Cr. (Mar 2024) to 12.11 Cr., marking a decrease of 0.22 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.49 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 0.49 Cr..
• For Investments, as of Mar 2025, the value is 1.69 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 1.69 Cr..
• For Other Assets, as of Mar 2025, the value is 13.30 Cr.. The value appears strong and on an upward trend. It has increased from 12.75 Cr. (Mar 2024) to 13.30 Cr., marking an increase of 0.55 Cr..
• For Total Assets, as of Mar 2025, the value is 27.10 Cr.. The value appears to be declining and may need further review. It has decreased from 27.26 Cr. (Mar 2024) to 27.10 Cr., marking a decrease of 0.16 Cr..

However, the Borrowings (10.84 Cr.) are higher than the Reserves (6.29 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Command Polymers Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 0.60. This value is below the healthy minimum of 5. It has increased from -2.16 (Mar 24) to 0.60, marking an increase of 2.76.
• For Diluted EPS (Rs.), as of Mar 25, the value is 0.60. This value is below the healthy minimum of 5. It has increased from -2.16 (Mar 24) to 0.60, marking an increase of 2.76.
• For Cash EPS (Rs.), as of Mar 25, the value is 1.38. This value is below the healthy minimum of 3. It has increased from -1.39 (Mar 24) to 1.38, marking an increase of 2.77.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 16.70. It has increased from 16.11 (Mar 24) to 16.70, marking an increase of 0.59.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 16.70. It has increased from 16.11 (Mar 24) to 16.70, marking an increase of 0.59.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 12.19. It has increased from 11.72 (Mar 24) to 12.19, marking an increase of 0.47.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 2.10. This value is within the healthy range. It has increased from -0.83 (Mar 24) to 2.10, marking an increase of 2.93.
• For PBIT / Share (Rs.), as of Mar 25, the value is 1.32. This value is within the healthy range. It has increased from -1.60 (Mar 24) to 1.32, marking an increase of 2.92.
• For PBT / Share (Rs.), as of Mar 25, the value is 0.41. This value is within the healthy range. It has increased from -2.35 (Mar 24) to 0.41, marking an increase of 2.76.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 0.59. This value is below the healthy minimum of 2. It has increased from -2.16 (Mar 24) to 0.59, marking an increase of 2.75.
• For PBDIT Margin (%), as of Mar 25, the value is 17.23. This value is within the healthy range. It has increased from -7.13 (Mar 24) to 17.23, marking an increase of 24.36.
• For PBIT Margin (%), as of Mar 25, the value is 10.81. This value is within the healthy range. It has increased from -13.62 (Mar 24) to 10.81, marking an increase of 24.43.
• For PBT Margin (%), as of Mar 25, the value is 3.37. This value is below the healthy minimum of 10. It has increased from -20.00 (Mar 24) to 3.37, marking an increase of 23.37.
• For Net Profit Margin (%), as of Mar 25, the value is 4.89. This value is below the healthy minimum of 5. It has increased from -18.39 (Mar 24) to 4.89, marking an increase of 23.28.
• For Return on Networth / Equity (%), as of Mar 25, the value is 3.57. This value is below the healthy minimum of 15. It has increased from -13.38 (Mar 24) to 3.57, marking an increase of 16.95.
• For Return on Capital Employeed (%), as of Mar 25, the value is 6.47. This value is below the healthy minimum of 10. It has increased from -7.87 (Mar 24) to 6.47, marking an increase of 14.34.
• For Return On Assets (%), as of Mar 25, the value is 2.06. This value is below the healthy minimum of 5. It has increased from -7.41 (Mar 24) to 2.06, marking an increase of 9.47.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.20. This value is within the healthy range. It has decreased from 0.23 (Mar 24) to 0.20, marking a decrease of 0.03.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.69. This value is within the healthy range. It has decreased from 0.71 (Mar 24) to 0.69, marking a decrease of 0.02.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.42. It has increased from 0.40 (Mar 24) to 0.42, marking an increase of 0.02.
• For Current Ratio (X), as of Mar 25, the value is 1.66. This value is within the healthy range. It has increased from 1.44 (Mar 24) to 1.66, marking an increase of 0.22.
• For Quick Ratio (X), as of Mar 25, the value is 0.63. This value is below the healthy minimum of 1. It has increased from 0.50 (Mar 24) to 0.63, marking an increase of 0.13.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.22. This value is below the healthy minimum of 4. It has decreased from 2.98 (Mar 24) to 1.22, marking a decrease of 1.76.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.32. This value is below the healthy minimum of 3. It has increased from -1.12 (Mar 24) to 2.32, marking an increase of 3.44.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.66. This value is below the healthy minimum of 3. It has increased from -1.88 (Mar 24) to 1.66, marking an increase of 3.54.
• For Enterprise Value (Cr.), as of Mar 25, the value is 45.90. It has increased from 34.05 (Mar 24) to 45.90, marking an increase of 11.85.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.02. This value exceeds the healthy maximum of 3. It has increased from 3.10 (Mar 24) to 4.02, marking an increase of 0.92.
• For EV / EBITDA (X), as of Mar 25, the value is 23.30. This value exceeds the healthy maximum of 15. It has increased from -43.44 (Mar 24) to 23.30, marking an increase of 66.74.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.10. This value exceeds the healthy maximum of 3. It has increased from 2.17 (Mar 24) to 3.10, marking an increase of 0.93.
• For Price / BV (X), as of Mar 25, the value is 2.26. This value is within the healthy range. It has increased from 1.58 (Mar 24) to 2.26, marking an increase of 0.68.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.10. This value exceeds the healthy maximum of 3. It has increased from 2.17 (Mar 24) to 3.10, marking an increase of 0.93.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has increased from -0.08 (Mar 24) to 0.01, marking an increase of 0.09.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness